Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI biotech startup Coefficient Bio in a $400 million stock deal, according to ...

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a team of fewer than 10 ...

Molecular Biology is the field of biology that studies the composition, structure and interactions of cellular molecules such as nucleic acids and proteins that carry out the biological processes ...

Chemical biology is the study of the chemicals and chemical reactions involved in biological processes, incorporating the disciplines of bioorganic chemistry, biochemistry, cell biology and ...

Anthropic is making strides in the AI space. The AI firm has acquired stealth startup Coefficient Bio for over $400 million in an all-stock deal. Closed in early April 2026, the acquisition pulls a ...

For two decades, Luis Martinez has fought wildfires for the U.S. government. Now he’s facing down cancer, debt and the threat of separation from his 11-year-old. By Hannah Dreier and Loren Elliott ...

We're dedicated to conducting cutting-edge, fundamental basic and translational research to improve human health and educating the next generation of scientists. Our faculty, staff, and trainees play ...

$25M grant will establish new interdisciplinary center composed of universities, including Boston College, and marine biology labs Boston College is one of 10 institutions of higher education and ...

Whether it’s a canary’s chirp or a treefrog’s croak, humans tend to prefer many of the same sounds that animals do themselves, a new study finds ...

Employers, lawmakers and more said regulators should hustle to get disclosure mandates for the controversial drug middlemen across the finish line, while PBMs slammed the rule as illegal, unnecessary ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...